 | Up a level |
Suana, A J; Tuffin, G; Frey, B M; Knudsen, L; Mühlfeld, C; Rödder, S; Marti, H-P (2011). Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis. Journal of pharmacology and experimental therapeutics, 337(2), pp. 411-22. Bethesda, Md.: American Society for Pharmacology and Experimental Therapeutics 10.1124/jpet.110.176222
Rödder, S; Scherer, A; Körner, M; Eisenberger, U; Hertig, A; Raulf, F; Rondeau, E; Marti, H-P (2010). Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients. American journal of transplantation, 10(2), pp. 286-97. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2009.02928.x
Rödder, S; Scherer, A; Raulf, F; Berthier, C C; Hertig, A; Couzi, L; Durrbach, A; Rondeau, E; Marti, H-P (2009). Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes. American journal of transplantation, 9(3), pp. 517-26. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2008.02512.x
Berthier, C C; Lods, N; Joosten, S A; van Kooten, C; Leppert, D; Lindberg, R L P; Kappeler, A; Raulf, F; Sterchi, E E; Lottaz, D; Marti, H-P (2006). Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets. Kidney international, 69(2), pp. 358-68. New York, N.Y.: Nature Publishing Group 10.1038/sj.ki.5000049
